ETR:SRT - Sartorius Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
€99.00 +0.80 (+0.81 %)
(As of 01/16/2019 07:20 AM ET)
Previous Close€98.20
Today's Range€97.20 - €99.60
52-Week RangeN/A
Volume131 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sartorius Aktiengesellschaft provides pharmaceutical and laboratory equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry. It provides filtration and purification, sterile filtration, virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, integrity testing, and OEM membranes; process analyzers, process control tools, microbiology products, and chemometric software; single-use bioprocess bags, containers, mixing systems, aseptic transfer systems, freeze and thaw systems, aseptic sampling and bottle closure systems, and tubing dis-/connectors; media USP and buffers DSP; bioreactors/fermentors; and FlexAct, a system that enables to custom-configure single-use solutions for entire biomanufacturing steps. The Lab Products & Services division provides laboratory instruments, such as lab balances, pipettes, and laboratory water purification systems; and consumables, including laboratory filters and pipette tips. Its products include OEM weigh cells, mass comparators and metrology, weights/weight sets, and paint mixing solutions; microbiology products and moisture analyzers; lab water systems; pipette tips and pipette calibration; bioreactors/fermentors and centrifuges; and filtration, ultrafiltration, membrane chromatography products, virus purification kits, diagnostic membranes and arrays, and blotting membranes, as well as aseptic bottle closure systems. The company also offers instrument, validation, and training services. It serves biopharmaceutical and pharmaceutical, public research institutes, and chemical and food sectors. The company was founded in 1870 and is headquartered in Goettingen, Germany.

Receive SRT News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone49 551 308 0

Debt

Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Price / Cash FlowN/A
Price / BookN/A

Profitability

Net IncomeN/A
Net MarginsN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
OptionableOptionable

Sartorius (ETR:SRT) Frequently Asked Questions

What is Sartorius' stock symbol?

Sartorius trades on the ETR under the ticker symbol "SRT."

What price target have analysts set for SRT?

8 analysts have issued 1-year price targets for Sartorius' stock. Their forecasts range from €93.00 to €142.00. On average, they anticipate Sartorius' share price to reach €114.88 in the next twelve months. This suggests a possible upside of 16.0% from the stock's current price. View Analyst Price Targets for Sartorius.

What is the consensus analysts' recommendation for Sartorius?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius in the last year. There are currently 4 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Sartorius.

Has Sartorius been receiving favorable news coverage?

News coverage about SRT stock has been trending positive on Wednesday, according to InfoTrie. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sartorius earned a news sentiment score of 2.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 7.0 out of 10, indicating that recent media coverage is likely to have an impact on the stock's share price in the next several days.

Who are some of Sartorius' key competitors?

Who are Sartorius' key executives?

Sartorius' management team includes the folowing people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 53)
  • Mr. Rainer Lehmann, CFO & Member of Exec. Board (Age 42)
  • Mr. Reinhard Vogt, Head of Bioprocess Solutions Division & Member of the Exec. Board (Age 63)
  • Ms. Petra Kirchhoff, VP of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 49)
  • Mr. Osacr-Werner Reif, Chief Technology Officer

What is Sartorius' stock price today?

One share of SRT stock can currently be purchased for approximately €99.00.

What is Sartorius' official website?

The official website for Sartorius is http://www.sartorius.com.

How can I contact Sartorius?

The company can be reached via phone at 49 551 308 0.


MarketBeat Community Rating for Sartorius (ETR SRT)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  35 (Vote Underperform)
Total Votes:  55
MarketBeat's community ratings are surveys of what our community members think about Sartorius and other stocks. Vote "Outperform" if you believe SRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel